Duchenne Gene Therapy Will Undergo Changes After Patient Deaths

(MedPage Today) — At the FDA’s request, delandistrogene moxeparvovec (Elevidys), the only approved gene therapy for Duchenne muscular dystrophy, will carry a black box warning for acute liver injury and acute liver failure, drugmaker Sarepta Therapeutics…

Source link : https://www.medpagetoday.com/neurology/generalneurology/116559

Author :

Publish date : 2025-07-17 20:04:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30

Duchenne Gene Therapy Will Undergo Changes After Patient Deaths

Farm Women With Rheumatoid Arthritis: Are Pesticides to Blame?

Doctors Who Use AI Perceived Less Favorably, Survey Suggests

Related Posts

Apple Watch Users Will Soon Get Hypertension Notifications

Dexcom Issues Recall for G7, ONE+ Apps for Software Issues

EHR Interoperability May Be Coming Closer to Reality

Schumer Warns of Shutdown if Republicans Don’t Accept Democrats’ Healthcare Demands

U.S. Officials to Link 25 Child Deaths to COVID Shots, Report Says

ATA Issues New Guidelines for Differentiated Thyroid Cancer

Apple Watch Users Will Soon Get Hypertension Notifications

Dexcom Issues Recall for G7, ONE+ Apps for Software Issues

EHR Interoperability May Be Coming Closer to Reality

Schumer Warns of Shutdown if Republicans Don’t Accept Democrats’ Healthcare Demands

U.S. Officials to Link 25 Child Deaths to COVID Shots, Report Says

ATA Issues New Guidelines for Differentiated Thyroid Cancer

Good Results With Same-Day Bilateral Cataract Surgery, Little Impact on Home Life

Flu Hospitalizations Hit Record Highs Last Season, CDC Says

Categories

Archives